These interactions have implicated NRP1 in cancer progression across multiple tumor types [15], where high NRP1 expression is associated with poor outcome in lung [19], glioblastoma [20], prostate [21] and breast cancers [22]. The gene discussed is NRP1; the disease is neoplasm.